Yinhua CSI Brand Name Drug Industry ETF (SHE:159992)
0.9010
-0.0090 (-0.99%)
At close: Oct 23, 2025
-0.99% (1Y)
Assets | n/a |
Expense Ratio | 0.55% |
PE Ratio | n/a |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Ex-Dividend Date | n/a |
Payout Frequency | n/a |
Payout Ratio | n/a |
1-Year Return | +22.42% |
Volume | 897,820,229 |
Open | 0.9070 |
Previous Close | 0.9100 |
Day's Range | 0.8910 - 0.9090 |
52-Week Low | 0.6480 |
52-Week High | 1.0280 |
Beta | n/a |
Holdings | n/a |
Inception Date | Mar 20, 2020 |
About 159992
159992.SZ was created on 2020-03-20 by Yinhua. The fund's investment portfolio concentrates primarily on health care equity. The Fund adopts passive indexation investment, closely tracks the index of the underlying object, and seeks tracking deviation and tracking errorMinimize
Asset Class Equity
Category Health Care
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 159992
Provider Yinhua
Index Tracked CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross
Performance
159992 had a total return of 22.42% in the past year, including dividends. Since the fund's inception, the average annual return has been -2.61%.